期刊文献+

胰升糖素样肽1及其类似物在胰岛移植中的应用前景 被引量:1

原文传递
导出
摘要 胰升糖素样肽1(GLP-1)对胰岛β细胞的保护效应是近年来研究的热点.体外研究和动物实验均已证实,使用GLP-1及其类似物(exendin-4等)可以增加胰岛β细胞总量,其机制可能包括抑制胰岛β细胞凋亡、促进胰岛β细胞增殖和新生.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2010年第10期728-731,共4页 Chinese Journal of Diabetes
基金 国家863计划资助项目(2006AA02A112) 国家自然科学基金资助项目(30771032 30700879)
  • 相关文献

参考文献21

  • 1Ballinger WF,Lacy PE.Transplantation of intact pancreatic islets in rats.Surgery,19720 72:175-186.
  • 2Najarian JS,Sutherland DE,Baumgartner D,et al.Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis.Ann Surg,1980,192:526-542.
  • 3Pyzdrowski KL,Kendall DM,Halter JB,et al.Preserved insulin secretion and insulin independence in recipients of islet autografts.N Engl J Med,1992,327:220-226.
  • 4Shapiro AM,Lakey JR,Ryan EA,et al.Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.N Engl J Med,2000,343:230-238.
  • 5Shapiro AM,Ricordi C,Hering BJ,et al.International trial of the Edmonton protocol for islet transplantation.N Engl J Med,2006,355:1318-1330.
  • 6Ryan EA,Paty BW,Senior PA,et al.Five-year follow-up after clinical islet transplantation.Diabetes,2005,54:2060-2069.
  • 7Kin T,Senior P,O'Gorman D,et al.Risk factors for islet loss during culture prior to transplantation.Transpl Int,2008,21:1029-1035.
  • 8Parkes DG,Pittner R,Jodka C,et al.Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.Metabolism,2001,50:583-589.
  • 9Sato A,Wang PC,Ohgawara H.Effect of stimulators such as GLP-1,PACAP,and nicotinamide on glucose-stimulated insulin secretion from porcine pancreatic endocrine cells in longterm culture.Pancreas,2002,25:86-93.
  • 10Hardikar AA,Wang XY,Williams LJ,et al.Functional maturation of fetal porcine β-cells by glucagon-like peptide 1 and cholecystokinin.Endocrinology,2002,143:3505-3514.

同被引文献35

  • 1Nathan D.Long-team complication of diabetes mellitus.N Engl J Med.1993;328:1676-1684.
  • 2Diabetes Control and Complications Trial Research Group.The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med.1993; 329:977-986.
  • 3Bloomgarden ZT.American diabetes Association postgraduate course, 1996: Treatment and prevention of diabetes.Diabetes Care.1996;19:784-786.
  • 4Sutherland DE, Gruessner AC, Gruessner RW.Pancreas transplantation: A review.Transplant Proc.1998;30: 1940-1943.
  • 5Fioretto P, Steffes MW, Sutherland DR, et al.Reversal of lesions of diabetic nephropathy after pancreas transplantation.N Engl J Med.1998;339(2):69-75.
  • 6Tyden G, Bolinder J, Solders G,et al.Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation.Transplantation.1999;67:645-648.
  • 7Shapiro AM, Lakey JR, Paty BW, et al.Strategic opportunities in c1inical islet transplantation.Transplantation.2005;79: 1304-1307.
  • 8Shapiro AM, Rieordi C, Hering BJ, et al.Internationa1 tria1 of the Edmonton Protocol for islet transplantation.N Engl J Med.2006;355:1318-1330.
  • 9Wakai A.Effect of adenosine on ischemia-reperfusion injury associated with rat pancreas transplantation.Br J Surg.2002; 89:494-496.
  • 10Li Y, Hansotia T, Yusta B, et al.Glucagon-like-peptide-1 receptor signaling modulates β cell apoptosis.J Biol Chem.2003;278:471-478.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部